BioSig Technologies, Inc.

Receive alerts
Market Cap:
$100.14 m
3.36 USD
52 weeks high
52 weeks low

In brief

BioSig Technologies, Inc., a development stage medical device company, engages in developing a proprietary biomedical signal processing technology platform to extract information from physiologic signals. Its product is PURE (Precise Uninterrupted Real-time evaluation of Electrograms) EP System, a surface electrocardiogram and intracardiac multichannel recording and analysis system that acquires, processes, and displays electrocardiogram and electrograms required during electrophysiology studies and catheter ablation procedures. It is also developing a library of software tools that are designed to be configured to fit the needs of electrophysiologists in various settings and for arrhythmia treatments. The company was founded in 2009 and is headquartered in Los Angeles, California.

Insight Widest with the analysis, Proactive gives perspectives that others don't.

Proactive's latest virtual event highlights a trio of rising stars in medicine and agriculture

The three companies participating in the event are medical device developer BioSig Technologies Inc, gene therapy company Genprex Inc and agriculture technology company Clean Seed Capital Group

on 08/04/2020